Glenmark Pharma’s arm receives USFDA’s approval for Pimecrolimus Cream

30 Aug 2019

Glenmark Pharmaceuticals’ subsidiary -- Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (USFDA) for Pimecrolimus Cream, 1%, a generic version of Elidel Cream, 1%, of Bausch Health US, LLC.

According to IQVIA sales data for the 12 month period ending July 2019, the Elidel Cream, 1% market achieved annual sales of approximately $198.8 million.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Related Glenmark Pharmaceuticals Ltd. Links:

Glenmark Pharma Share Price

479.15 -6.00 (-1.24%) Oct 28, 17:13
1 Year Price Chart
Company Name CMP
Sun Pharma Inds. 463.35
Dr. Reddys Lab 4949.80
Lupin 940.40
Piramal Enterprises 1282.05
Cadila Healthcare 418.45
View more..
Sensex vs Glenmark Pharma
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719